Sign In
Buy TNXP
$12.53
-0.500 (-3.84%)
At Close: Jul 10, 2026
Tonix Pharmaceuticals to Present at 3rd Annual Neuropsychiatric Drug Development Summit
04:15pm, Monday, 09'th Nov 2020
CHATHAM, N.J., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederm
Tonix Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights
08:30am, Monday, 09'th Nov 2020
Data from Animal Studies of COVID-19 Vaccine Candidate, TNX-1800, Expected in Fourth Quarter 2020
